Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Healthcare Editor
UK
+20 year(s) experience
Medtech Insight
Germany’s authorities are back on guard against COVID-19 following renewed regional outbreaks. Diagnostics manufacturers will continue to play a strong part in bringing the pandemic substantially under control, a recent industry association virtual conference heard.
Medtech Insight
Better health care infrastsructures, enhanced digital capabilities and temporary VAT cuts are part the German coalition government’s new investment plan to revive the economy in aftermath of COVID-19.
Medtech Insight
Germany is behind with its COVID-19 contract tracing app, having switched from a centralized to a decentralized concept, but the app will be ready in the event of a second – or third – wave of infection.
Topic Coronavirus
Medtech Insight
Roche Diagnostics is promising a €400m investment at the site in Bavaria that has developed its new COVID-19 antibody test kits, three million of which will be delivered to German health care professionals in May.
Topic Coronavirus
Medtech Insight
The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings.
In Vivo
For providers and medtech manufacturers alike, the decade ahead will be a time of coming to terms with digital technologies and integrating new methods of payment. Quality of service delivery remains the market entry criterion, but companies will have to adapt to evolving health care delivery models. The stakes are implausibly high. Will they be able to capitalize on the changes in a market that is more competitive and unpredictable than ever?
In Vivo
In a world where national economies are beset by conflicting spending priorities, health care is oftentimes too low on the agenda, health care observers say. One of these is Boston Scientific senior vice-president Eric Thépaut, who understands the dilemmas, but says that health care will soon force its way up the priority list. He has advice for future-ready medtech innovators.
Topic Medtech Business strategies
In Vivo
Medtech’s contribution to health care improvements in Europe over the past 30 years has been a phenomenal journey of success – in patient terms as well as in commercial terms, says MedTech Europe chair Rob ten Hoedt. Local creativity has been able to mine a seam of product innovation that is unmatched anywhere in the world, but the sector is facing massive change and must find ways to cope.
Topic Medtech Digital Health
In Vivo
Value is a concept that is increasingly embraced by providers and payers, as well as medtech manufacturers. Leading providers are organizing around value, changing their models and thereby inviting medtech manufacturers to adapt to the post fee-for-service era. Some, like Medtronic, are at the head of the game.
In Vivo
Drug delivery technology specialist Consort Medical has capitalized on device respiratory expertise for 50 years, but a renewed focus on strategic expansion has seen it make an IP play, move into the pharma side and target other delivery formats for global pharma industry customers. Its enhanced capabilities will keep rivals on their toes.
Topic Drug review Drug approval
Medtech Insight
The EU Medical Device Regulation is 15 months away from being implemented in full, and a new German survey about its potential impact on the medtech innovation and patient-care landscape makes for sobering reading.
Topic Medtech
In Vivo
The health products industry, methods of care delivery and even the public's expectations for improved tools to prevent, monitor and treat disease have transformed dramatically in the past five years. The changes anticipated over a similar period ahead are potentially even more marked, with business continuity impacts for medtech and pharma concerns, according to Deloitte LLP experts who were on the circuit at health care industry events in Germany and the UK this spring.
Medtech Insight
Medtech regulatory fees in the Philippines are being increased for the first time since 2001. The country's FDA says the new fees will support quality improvements.
Topic Policy and regulation
In Vivo
Johnson & Johnson's DePuy Synthes orthopedic business has taken a measured view of digital and robotic capabilities, rather than acquiring assets that perhaps do not fully meet its strategic needs. For the business's global R&D head Euan Thomson, any new technology must augment the group's abilities to drive meaningful outcomes.
Topic Digital Health
In Vivo
The leading medtechs are starting to develop models for providers that show how to implement successful digital strategies, a trend that is serving to put pressure on companies that are yet to make a commitment, says ZS Associates' Pete Masloski.
Topic Digital Health
Medtech Insight
09 Jul 2020
In Vivo
08 Jul 2020
Medtech Insight
08 Jul 2020
In Vivo
06 Jul 2020
Medtech Insight
03 Jul 2020
Medtech Insight
02 Jul 2020
In Vivo
01 Jul 2020
Medtech Insight
01 Jul 2020
Medtech Insight
29 Jun 2020
Medtech Insight
29 Jun 2020
Medtech Insight
26 Jun 2020
Medtech Insight
24 Jun 2020
Medtech Insight
24 Jun 2020
In Vivo
23 Jun 2020
Medtech Insight
07 May 2020
Tweets from Ashley